“…In addition, studies have documented several adverse health effects, such as hepatotoxicity, nephrotoxicity, immunotoxicity, teratogenicity, mutagenicity, genotoxicity, and embryotoxicity (Wang et al, 2022) Given that medical Cannabis is used in the treatment of various diseases of the nervous system, neurodegenerative and affective disorders, as well as to modulate eating behavior and treat rheumatic disorders, it is important to consider the risk that the possible synthesis of ochratoxins may generate for consumers, taking into account that this mycotoxin is difficult to degrade during processing stages (Liu et al, 2022;Montero-Oleas et al, 2020;Pauli et al, 2020;Russo, 2018) To prevent OTA synthesis by A. westerdijkae and its contamination in cannabis, it is essential to adhere to recommendations such as implementing proper agricultural practices (GAP) during cultivation. Additionally, careful monitoring of environmental parameters during postharvest, including temperature, water activity (aw), pH, osmotic stress and the availability of carbon sources for the microorganism (Wang et al, 2023).…”